Inherited and somatic components in the pathogenetics of common diseases

It is known that the pathogenesis of common diseases (CDs) is determined by a complex and nonlinear interaction of genetic predisposition, epigenetic modifications, and environmental factors. However, in addition to inherited genetic variants, somatic mutations play a key role in the pathological phenotype, shaping cell-type-specific genetic landscapes and influencing regional predisposition of target organs, age of onset, and variability in clinical manifestations. Thus, according to current concepts, CDs develop as a result of the combined influence of inherited germline variants and somatic mutations acquired during life, the interaction of which is realized through cell-specific molecular networks. Therefore, this review sequentially examines the main factors, classical and modern models of complex pathological phenotypes, as well as the achievements and prospects of analyzing inherited genetic variants in relation to CDs. The role of somatic mutations in the development of pathology is discussed using the example of atherosclerosis ontogenesis and the concept of atherooncology through the assessment of somatic genomic variability in smooth muscle cells of atherosclerotic plaques, where the sequential accumulation of “driver” mutations confers a selective advantage and triggers clonal evolution in the tissue microenvironment. Special attention is given to the concept of “paradominant” inheritance – a special form of nonMendelian transmission of complex traits that combines inherited predisposition and somatic mutations that arise early in ontogenesis. Based on an analysis of current data, we propose an integrative hypothesis postulating that inherited genetic variants form a body-wide predisposition to CDs, while somatic mutations, arising and selectively increasing in specific cellular compartments of target organs, are critical events explaining the regional specificity, temporal dynamics (age of onset), and variability in the severity of the clinical phenotype. A new paradigm for predictive medicine for CDs is based on a comprehensive characterization of the continuum of genetic variants (inherited and somatic), an analysis of their interactions with cell-specific molecular networks, and a transition from population-based risk assessments to causal models of individual pathogenesis.

1. Baylis R.A., Gao H., Wang F., Bell C.F., Luo L., Björkegren J.L.M., Leeper N.J. Identifying shared transcriptional risk patterns between atherosclerosis and cancer. iScience. 2023;26(9):107513. doi 10.1016/j.isci.2023.107513

2. Benditt E.P., Benditt J.M. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA. 1973;70(6):17531756. doi 10.1073/pnas.70.6.1753

3. Boyle E.A., Li Y.I., Pritchard J.K. An expanded view of complex traits: from polygenic to omnigenic. Cell. 2017;169(7):1177-1186. doi 10.1016/j.cell.2017.05.038

4. Bragina E.Yu., Puzyrev V.P. Genetic outline of the hermeneutics of the diseases connection phenomenon in human. Vavilovskii Zhurnal Genetiki i Selektsii = Vavilov J Genet Breed. 2023;27(1):7-17. doi 10.18699/VJGB-23-03

5. DiRenzo D., Owens G.K., Leeper N.J. “Attack of the Clones”: commonalities between cancer and atherosclerosis. Circ Res. 2017; 120(4):624-626. doi 10.1161/CIRCRESAHA.116.310091

6. Dobnikar L., Taylor A.L., Chappell J., Oldach P., Harman J.L., Oerton E., Dzierzak E., Bennett M.R., Spivakov M., Jørgensen H.F. Disease-relevant transcriptional signatures identified in individual smooth muscle cells from healthy mouse vessels. Nat Commun. 2018;9(1):4567. doi 10.1038/s41467-018-06891-x

7. Fiziev P.P., McRae J., Ulirsch J.C., Dron J.S., Hamp T., Yang Y., Wainschtein P., … Marques-Bonet T., Rehm H.L., O’Donnell-Luria A., Khera A.V., Farh K.K. Rare penetrant mutations confer severe risk of common diseases. Science. 2023;380(6648):eabo1131. doi 10.1126/science.abo1131

8. Happle R. The McCune-Albright syndrome: a lethal gene surviving by mosaicism. Clin Genet. 1986;29(4):321-324. doi 10.1111/j.1399-0004.1986.tb01261.x

9. Happle R. Allelic somatic mutations may explain vascular twin nevi. Hum Genet. 1991;86(3):321-322. doi 10.1007/BF00202421

10. Happle R. Mosaicism in human skin. Understanding the patterns and mechanisms. Arch Dermatol. 1993;129(11):1460-1470

11. Happle R. Monoallelic expression on autosomes may explain an unusual heritable form of pigmentary mosaicism: a historical case revisited. Clin Exp Dermatol. 2009;34(7):834-837. doi 10.1111/j.1365-2230.2009.03543.x

12. Jaiswal S., Fontanillas P., Flannick J., Manning A., Grauman P.V., Mar B.G., Lindsley R.C., … Atzmon G., Wilson J.G., Neuberg D., Altshuler D., Ebert B.L. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371(26):2488-2498. doi 10.1056/NEJMoa1408617

13. Kabir I., Zhang X., Dave J.M., Chakraborty R., Qu R., Chandran R.R., Ntokou A., … Hwa J., Kluger Y., Martin K.A., Fernández-Hernando C., Greif D.M. The age of bone marrow dictates the clonality of smooth muscle-derived cells in atherosclerotic plaques. Nat Aging. 2023;3(1):64-81. doi 10.1038/s43587-022-00342-5

14. Knudson A.G. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA. 1971;68(4):820-823. doi 10.1073/pnas.68.4.820

15. Kojima Y., Volkmer J.P., McKenna K., Civelek M., Lusis A.J., Miller C.L., Direnzo D., … Maegdefessel L., Matic L.P., Hedin U., Weissman I.L., Leeper N.J. CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature. 2016;536(7614):86-90. doi 10.1038/nature18935

16. Koroleva Iu.A., Goncharova I.A., Zarubin A.A., Shipulina S.A., Sleptsov A.A., Panfilov D.S., Kozlov B.N., Nazarenko M.S. Methylation levels in the 5′ region of the TBX20 gene in the ascending aorta change in opposite direction in atherosclerosis and aneurysm. Russ J Genet. 2024;60(7):977-981. doi 10.1134/S102279542470042X

17. Limaye N., Wouters V., Uebelhoer M., Tuominen M., Wirkkala R., Mulliken J.B., Eklund L., Boon L.M., Vikkula M. Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat Genet. 2009;41(1):118-124. doi 10.1038/ng.272

18. Lin A., Brittan M., Baker A.H., Dimmeler S., Fisher E.A., Sluimer J.C., Misra A. Clonal expansion in cardiovascular pathology. JACC Basic Transl Sci. 2023;9(1):120-144. doi 10.1016/j.jacbts.2023.04.008

19. Luo L., Fu C., Bell C.F., Wang Y., Leeper N.J. Role of vascular smooth muscle cell clonality in atherosclerosis. Front Cardiovasc Med. 2023;10:1273596. doi 10.3389/fcvm.2023.1273596

20. Oren O., Libby P. Incorporating management of clonal hematopoiesis of indeterminate potential into cardiovascular practice. Circulation. 2025;152(14):975-977. doi 10.1161/CIRCULATIONAHA.125.075769

21. Pan H., Xue C., Auerbach B.J., Fan J., Bashore A.C., Cui J., Yang D.Y., … Califano A., Sims P.A., Zhang H., Li M., Reilly M.P. Single-cell genomics reveals a novel cell state during smooth muscle cell phenotypic switching and potential therapeutic targets for atherosclerosis in mouse and human. Circulation. 2020;142(21): 2060-2075. doi 10.1161/CIRCULATIONAHA.120.048378

22. Pan H., Ho S.E., Xue C., Cui J., Johanson Q.S., Sachs N., Ross L.S., Li F., Solomon R.A., Connolly E.S., Jr., Patel V.I., Maegdefessel L., Zhang H., Reilly M.P. Atherosclerosis is a smooth muscle cell- driven tumor-like disease. Circulation. 2024;149(24):1885-1898. doi 10.1161/CIRCULATIONAHA.123.067587

23. Puzyrev V.P., Kucher A.N. Evolutionary ontogenetic aspects of pathogenetics of chronic human diseases. Russ J Genet. 2011;47(12): 1395-1405. doi 10.1134/S102279541112012X

24. Schuermans A., Honigberg M.C. Clonal haematopoiesis in cardiovascular disease: prognostic role and novel therapeutic target. Nat Rev Cardiol. 2025;22(11):845-856. doi 10.1038/s41569-025-01148-9

25. Tao W., Yurdagul A., Jr., Kong N., Li W., Wang X., Doran A.C., Feng C., Wang J., Islam M.A., Farokhzad O.C., Tabas I., Shi J. siRNA nanoparticles targeting CaMKIIγ in lesional macrophages improve atherosclerotic plaque stability in mice. Sci Transl Med. 2020;12(553):eaay1063. doi 10.1126/scitranslmed.aay1063

26. Wang Y., Gao H., Wang F., Ye Z., Mokry M., Turner A.W., Ye J., … Björkegren J.L.M., Pasterkamp G., Miller C.L., Ross E.G., L eeper N.J. Dynamic changes in chromatin accessibility are asso ciated with the atherogenic transitioning of vascular smooth muscle cells. Cardiovasc Res. 2022;118(13):2792-2804. doi 10.1093/cvr/cvab347

27. Weldy C.S., Kundu S., Monteiro J., Gu W., Pedroza A.J., Dalal A.R., Worssam M.D., … Fischbein M.P., Engreitz J., Kundaje A.B., Cheng P.P., Quertermous T. Epigenomic landscape of single vascular cells reflects developmental origin and disease risk loci. Mol Syst Biol. 2025;21(11):1522-1546. doi 10.1038/s44320-025-00140-2